Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole

American Journal of Health-System Pharmacy

Volumn 67, Issue 2, 2010, Pages 123-127

  Chisholm Burns, Marie A ^a   Patanwala, Asad E ^a   Spivey, Christina A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Anemia; Hepatitis; Hypotension; Meningitis; Sulfamethoxazole; Sulfonamides; Toxicity; Trimethoprim; Urinary antiinfectives

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COTRIMOXAZOLE; METOCLOPRAMIDE; MORPHINE SULFATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASEPTIC MENINGITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DIZZINESS; DRUG WITHDRAWAL; EMERGENCY WARD; FATIGUE; FEVER; FOLLOW UP; GENERAL PRACTITIONER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS; HEPATOMEGALY; HUMAN; LUMBAR PUNCTURE; MACULOPAPULAR RASH; MALE; ORTHOSTATIC HYPERTENSION; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; RIGIDITY; SPEECH DISORDER; ULTRASOUND; URINARY TRACT INFECTION; WEAKNESS;

EID: 75149166699     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080558     Document Type: Article

References (20)

1. Goosens H, Ferech M, Coenen S et al., for the European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007; 44:1091-5.
2. Lacy CF, Armstrong LL, Goldman MP et al. Drug information handbook. 14th ed. Hudson, OH: Lexi-Comp; 2006.
3. McEvoy GK, Miller J, Litvak K, eds. AHFS drug information, 2005. Bethesda, MD: American Society of Health-System Pharmacists; 2005.
4. Johnson MP, Goodwin SD, Shands JW Jr. Trimethoprim-sulfamethoxazole anaphylactoid reactions in patients with AIDS: case reports and literature review. Pharmacotherapy. 1990; 10:413-6.
5. Gordin FM, Simon GL, Wofsy CB et al. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1984; 100:495-9.
6. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
7. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest. 1988; 82:1826-32.
8. Antonen J, Saha H, Hulkkonen J et al. Increased in vitro production of interleukin 6 in response to trimethoprim among persons with trimethoprim-induced systemic adverse reactions. J Rheumatol. 1999; 26:2585-90.
9. Sullivan JR, Shear NH. The drug hyper-sensitivity syndrome. What is the pathogenesis? Arch Dermatol. 2001; 137:357-64.
10. Shapiro L, Shear N. Mechanisms of drug reactions: the metabolic track. Semin Cutan Med Surg. 1996; 15:217-27.
11. Babcock HM. Aseptic meningitis. MedLinePlus medical encyclopedia 2006. www.nlm.nih.gov/medlineplus/ency/article/000614.htm (accessed 2007 Jun 29).
12. Reinke CM, Thomas JK, Graves AH. Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review. J Pharm Tech. 1995; 11:256-62.
13. G6PD Deficiency Favism Association. Clinical aspects of G6PD deficiency. An introduction to G6PD deficiency, www.favism.org/g6pd/clinical.htm (accessed 2007 Jun 7).
14. Yoshida A, Beutler E. Glucose-6-phosphate dehydrogenase. New York: Academic Press; 1986.
15. Owusu SK. Acute haemolysis complicating co-trimoxazole therapy for typhoid fever in a patient with G.-6-P.D. deficiency. Lancet. 1972; 2:819.
16. Tungsiripat M, Dreschler H, Sarlone C et al. Prevalence and significance of G6PD deficiency in patients of an urban HIV clinic. J Int Assoc Physicians AIDS Care. 2008; 7:88-90.
17. Calabro V, Cascone A, Malaspina P et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism. Haematologica. 1989; 74:71-3.
18. Taraszewski R, Harvey R, Rosman P. Death from drug-induced hemolytic anemia. Postgrad Med. 1989; 85:79-80.
19. Chan TK, McFadzean AJ. Haemolytic effect of trimethoprim- sulphamethoxazole in G-6-PD deficiency. Trans R Soc Trop Med Hyg. 1974; 68:61-2.
20. Markowitz N, Saravolatz LD. Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase deficient population. Rev Infect Dis. 1987; 9(suppl 2):S218-29.